Skip to main content
Top

Annals of Hematology

Issue 12/2024

Content (120 Articles)

MDS patient registries - achievements and challenges

Tilman Steinmetz, Uwe Totzke, Annika Kasprzak, Stephan Schmitz, Norbert Gattermann, Ulrich Germing

The role of long noncoding RNAs in the diagnosis, prognosis and therapeutic biomarkers of acute myeloid leukemia

Aytenew Atnaf, Yibeltal Akelew, Desalegn Abebaw, Yalew Muche, Melese Getachew, Hylemariam Mihiretie Mengist, Aster Tsegaye

mTOR inhibitors potentially preserve fertility in female patients with haematopoietic malignancies: a narrative review

Yuji Tanaka, Tsukuru Amano, Akiko Nakamura, Mari Deguchi, Akimasa Takahashi, Shunichiro Tsuji, Takashi Murakami

Vaccine challenges in CLL: a comprehensive exploration of efficacy of SARS-CoV-2 immunization for patients with chronic lymphocytic leukemia

Christina-Nefeli Kontandreopoulou, Elena E. Solomou, Epaminondas Kolorizos, Panagiotis T. Diamantopoulos

DNMT3A-R882: a mutation with many paradoxes

Pourya Arbab Jafari, Ramin Bagheri, Soroush Lavasani, Sajad Goudarzi

Update on kidney injury caused by multiple myeloma

Linhui Wang, Chen Liu, Haiyan Song, Jing Yuan, Yan Zha, Yiyao Deng

Advances in hematopoietic stem cells ex vivo expansion associated with bone marrow niche

  • Review Article

Ju Deng, Yanhong Tan, Zhifang Xu, Hongwei Wang

Neutrophil extracellular traps - an a-list-actor in a variety of diseases

  • Review

Na Wang, Xiao-Lin Shi, Dan Li, Bin-Bin Li, Peng Liu, Hong Luo

Advances in epigenetic therapies for B-cell non-hodgkin lymphoma

Weiwen Hu, Lanlan Zang, Xiaoxi Feng, Shuhui Zhuang, Liudi Chang, Yongjing Liu, Jinyan Huang, Yuanyuan Zhang

Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease

Irene Motta, Paola Delbini, Natalia Scaramellini, Viola Ghiandai, Lorena Duca, Isabella Nava, Fabio Nascimbeni, Simonetta Lugari, Dario Consonni, Elena Trombetta, Valeria Di Stefano, Margherita Migone De Amicis, Elena Cassinerio, Francesca Carubbi, Maria Domenica Cappellini

Pre-diagnostic trajectory of pediatric hemophagocytic lymphohistiocytosis: observations from hematological and hepatic parameters

Xun Li, Haipeng Yan, Zili Cai, Xiao Li, Longlong Xie, Ting Luo, Xiangyu Wang, Yufan Yang, Ling Gong, Minghui Tang, Xinping Zhang, Jiaotian Huang, Xiulan Lu, Zhenghui Xiao

The effects of complement-independent, autoantibody-induced apoptosis of platelets in immune thrombocytopenia (ITP)

Lin Sun, Yichen Zhang, Ping Chen, Nan Jiang, Qi Feng, Shuqian Xu, Jun Peng, Zi Sheng

Integrated metabolomic and microbiome analysis identifies Cupriavidus metallidurans as a potential therapeutic target for β-thalassemia

Xianfeng Guo, Sheng Lin, Xuchao Zhang, Min Li, Zi Wang, Yuanliang Peng, Xiaofeng He, Jing Liu

Predictors for spontaneous remission in childhood chronic immune thrombocytopenia

Yuan-Ning Yang, Yun-Hsuan Yeh, Jiann-Shiuh Chen, Li-Wen Chen, Yung-Chieh Lin, Chao-Neng Cheng

Health-related quality of life and symptom-specific functional impairment among patients treated with parenterally administered complement inhibitors for paroxysmal nocturnal hemoglobinuria

David Dingli, Avery A. Rizio, Lynne Broderick, Kaitlin LaGasse, Sloan Rucker, Michelle K. Carty, Elise Burton, Shaquilla Gordon, Glorian P. Yen, Jincy Paulose, Anumaxine Geevarghese, Soyon Lee

Real-world experience with iron chelation therapy in transfusion-dependent thalassemia: impact of the oral chelators’ era

Morgan Pines, Dorothy Kleinert, Charlene Thomas, Cheryl Mensah, Khaled M. Musallam, Sujit Sheth

Livedoid vasculopathy in hemoglobinopathy-associated chronic leg ulcers

Harish Eswaran, Samuel Wilson, Jane Little, Stephan Moll

Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registry

S. Mathur, G. Christou, R. Delage, M. Elemary, N. Finn, M. Geddes, DS. Houston, MM. Keating, D. Khalaf, B. Leber, H. Leitch, SA. Lother, L. Mozessohn, T. Nevill, A. Parmentier, K. Paulson, E. Rimmer, M. Sabloff, A. Shamy, E. St-Hilaire, J. Storring, K. Yee, L. Zhang, N. Zhu, AE. Hay, R. Zarychanski, R. Buckstein, Brett L. Houston

Immune checkpoints PD1/PDL1, TIM3/GAL9 and key immune mediators landscape reveal differential expression dynamics on imatinib response in chronic myeloid leukemia

María Jazmín Toloza, Marco Lincango, María Fernanda Camacho, Martin Manuel Ledesma, Alicia Enrico, Beatriz Moiraghi, Fernanda Tosin, Romina Mariano, Mariel Pérez, Pedro Negri Aranguren, María Elisa Riva, Irene B. Larripa, Carolina B. Belli

Beneficial effects of cellular immunotherapy in the prevention and treatment of posttransplant hematologic relapse of myelodysplastic neoplasms

Gi-June Min, Sung Soo Park, Silvia Park, Jae-Ho Yoon, Sung-Eun Lee, Byung Sik Cho, Ki-Seong Eom, Hee-Je Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Yoo-Jin Kim

Investigation of TSRP reverses imatinib resistance through the PI3K / Akt pathway in chronic myeloid leukemia

Ying He, Jiyuan Ding, Liqin Liu, Jiajun Chen, Hong Zhong, Changyu Li, Xiaofeng Xu

Distinct clinical profiles and patient outcomes in aCML and CNL

Yingxin Sun, Qinrong Wang, Zhiyu Zhang, Qian Wang, Jiannong Cen, Mingqing Zhu, Jinlan Pan, Dandan Liu, Hongjie Shen, Yifeng Cai, Suning Chen

FLT3 inhibitors and hematopoietic cell transplantation prolong survival in patients with FLT3-ITD-positive AML

Toshihiro Matsukawa, Masahiro Onozawa, Takeshi Kondo, Minoru Kanaya, Daisuke Hidaka, Shuichi Ota, Akio Mori, Akio Shigematsu, Takuto Miyagishima, Yasutaka Kakinoki, Junichi Hashiguchi, Satoshi Yamamoto, Masayo Yamamoto, Kentaro Wakasa, Mutsumi Takahata, Toshimichi Ishihara, Yoshihito Haseyama, Akihito Fujimi, Tetsuya Igarashi, Takehiro Sarashina, Satoshi Iyama, Ryoji Kobayashi, Hajime Sakai, Katsuya Fujimoto, Junki Inamura, Yuji Kanisawa, Shinsuke Hirabayashi, Tomoyuki Endo, Daigo Hashimoto, Takanori Teshima

Health-related quality of life benefits of arsenic trioxide in patients with non-high-risk acute promyelocytic leukemia are sustained over time: long-term results of the GIMEMA APL0406 trial

Fabio Efficace, Francesco Sparano, Massimo Breccia, Corinna Greco, Paola Carluccio, Erika Borlenghi, Prassede Salutari, Luciano Levato, Thomas Baldi, Valentina Mancini, Olimpia Finizio, Francesco Autore, Paola Fazi, Uwe Platzbecker, Marco Vignetti, Maria Teresa Voso

Overall survival in TP53-mutated AML and MDS

Christian J. Puzo, Karl M. Hager, Henry M. Rinder, Olga K. Weinberg, Alexa J. Siddon

Supportive care strategies in myelodysplastic syndromes and acute myeloid leukemia in older adults: a national survey of Canadian hematologists

Anna R. Blankstein, Nora Choi, Lee Mozessohn, David Sanford, Kristjan Paulson, Emily Rimmer, Donald S. Houston, Sylvain A. Lother, Asher Mendelson, Allan Garland, Ryan Zarychanski, Annette E. Hay, Rena Buckstein, Brett L. Houston

Different prognosis according to treatment in patients with acute promyelocytic leukemia: How the outcome changed over time

Emilia Scalzulli, Alessandro Costa, Ida Carmosino, Paolo Musiu, Maria Laura Bisegna, Maria Stefania De Propris, Claudia Ielo, Daniela Diverio, Clara Minotti, Saveria Capria, Roberto Latagliata, Maurizio Martelli, Massimo Breccia

Central nervous system relapse after allogeneic HCT in FLT3-mutated AML

Khouloud Kouidri, Fabian Acker, Rosa Toenges, Saskia Pfaff, Sarah Lindner, Julia Riemann, Marek Werth, Salem Ajib, Fabian Lang, Björn Steffen, Thomas Oellerich, Hubert Serve, Anjali Cremer, Gesine Bug

Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experience

Benjamin J. Lee, Shawn P. Griffin, Jean Doh, Stefan O. Ciurea, Deepa Jeyakumar, Piyanuch Kongtim, Kiran Naqvi

All-trans retinoic acid potentiates cell death induced by quizartinib in acute myeloid leukemia with FLT3-ITD mutations

Silvia Elena Sánchez-Mendoza, Virginia Mara de Deus-Wagatsuma, Mariane Cristina do Nascimento, Keli Lima, João Agostinho Machado-Neto, Mojgan Djavaheri-Mergny, Eduardo Magalhães Rego

Survival impact of hypoxia-inducible factor-1 alpha (HIF-1α) in Nucleophosmin1 mutated acute myeloid leukemia

Chantiya Chanswangphuwana, Narittee Sukswai, Nichthida Tangnuntachai, Ponlapat Rojnuckarin

Enhancing outcomes of childhood acute lymphoblastic leukemia in workplace diversity in Thailand: multicenter study on behalf of the Thai Pediatric Oncology Group

Chalinee Monsereenusorn, Piti Techavichit, Lalita Sathitsamitphong, Nawachai Lertvivatpong, Angkana Winaichatsak, Su-on Chainansamit, Jassada Buaboonnam, Pitchayanan Kuwatjanakul, Thirachit Chotsampancharoen, Chonthida Wangkittikal, Kittima Kanchanakamhaeng, Kunanya Suwannaying, Pariwan Sripattanatadasakul, Siranee Wongruangsri, Nattaporntira Phalakornkul, Oranooj Lertkovit, Phakatip Sinlapamongkolkul, Pokpong Na Songkhla, Kerati Prasertphol, Samart Pakakasama, Piya Rujkijyanont, Pankamol Siriwattanukul, Hansamon Poparn, Sureeporn Chingnawan, Jutiphong Boonmuang, Napat Laoarun, Sudarat Tassanasuwan, Daranee Isaranimitkul

Flow cytometric expression of Bcl-2, Mcl-1, and their ratios correlates with primary and secondary cytogenetic changes and their combinations in multiple myeloma

Shelly Singla, Sreejesh Sreedharanunni, Archana Singh, Charanpreet Singh, Parveen Bose, Arun Kumar, Anand Balakrishnan, Arihant Jain, Alka Khadwal, Deepesh Lad, Gaurav Prakash, Praveen Sharma, Nabhajit Mallik, Man Updesh Singh Sachdeva, Reena Das, Pankaj Malhotra

Real-world outcomes of diffuse large B-cell lymphoma treated with frontline R-CHOP(-like) regimens in an Asian multi-ethnic population

Ryan Mao Heng Lim, Jing Yuan Tan, Ya Hwee Tan, Zane En Qi Heng, Lawrence Cheng Kiat Ng, Francesca Lorraine Wei Inng Lim, Yeow Tee Goh, Soon Thye Lim, Jason Yongsheng Chan

Distinct pathway activities are associated with prognosis and response to bortezomib-containing treatment in MCL1-M based molecular subtypes of multiple myeloma

Yuan Yang, Sitao Jiang, Hang Du, Jingling Tang, Pengli Xiao, Yin Wu, Jiuyi Li, Jing Feng, Yanfei Wei, Ayaz Ali Samo, Xuzhang Lu, Xiaolong Fan

Impact of comorbidity on health-related quality of life in newly diagnosed patients with lymphoma or multiple myeloma: results from the PROFILES-registry

Afke Ekels, Lonneke V. van de Poll-Franse, Djamila E. Issa, Mels Hoogendoorn, Marten R. Nijziel, Adrianus Koster, Cornelis N. de Jong, Ahmed Achouiti, Noortje Thielen, Lidwine W. Tick, Liane C. J. te Boome, Lara H. Bohmer, Nicolette L. Tiren-Verbeet, Gerrit J. Veldhuis, Fransien de Boer, Marjolein van der Klift, Eduardus F. M. Posthuma, Simone Oerlemans

Comparison of tucidinostat with CHOP-like versus CHOP-like in first-line treatment of peripheral T-cell lymphoma: a single-center real-world study

Xiaolian Wen, Tao Guan, Qinchuan Yu, Yanli Wang, Lieyang Wang, Yuping Zheng, Wei’e Han, Liping Su

Racial and ethnic disparities in outcomes of diffuse large B cell lymphoma in adolescent and young adults: a SEER database analysis

Sheeba Ba Aqeel, Muhammad Salman Faisal, Othman Salim Akhtar, Kristopher Attwood, Anthony George, Pragati Advani, Narendranath Epperla, Pallawi Torka

Non-linear relationship between soluble interleukin-2 receptor and prognosis of diffuse large B-cell lymphoma

Hikaru Tsukasaki, Kei Fujita, Shin Lee, Tetsuji Morishita, Kana Oiwa, Eiju Negoro, Takeshi Hara, Hisashi Tsurumi, Takanori Ueda, Takahiro Yamauchi

T(11;14) with multiple myeloma: Standard risk survival but slow and poor response

Yuntong Liu, Jingyu Xu, Wenqiang Yan, Yueshen Ma, Lingna Li, Jian Cui, Rui lv, Chenxing Du, Lugui Qiu, Gang An

Development and validation of prognostic models based on 18F-FDG PET radiomics, metabolic parameters, and clinical factors for elderly DLBCL patients

Tianshuo Yang, Zhuxu Sun, Yuye Shi, Yue Teng, Luyi Cheng, Ronghua Zhu, Huai Zhang, Qiuhu Wang, Jing Wei, Chongyang Ding, Weijing Tao

Optimizing resources: low-dose nivolumab combinations in the management of relapsed/refractory Hodgkin lymphoma

Perla R. Colunga-Pedraza, Héctor A. Vaquera-Alfaro, Zulia Guzmán-Martínez, Marion Carolina Alemán-Jiménez, Antonio Vega-Mateos, Andrés Gómez-De León, Luis Mario Villela, David Gómez-Almaguer

Lymphocyte profile in peripheral blood of patients with multiple myeloma

Tereza Dekojová, Hana Gmucová, Diana Macečková, Robin Klieber, Pavel Ostašov, Martin Leba, Tomáš Vlas, Alexandra Jungová, Valentina S. Caputo, Miroslava Čedíková, Daniel Lysák, Pavel Jindra, Monika Holubová

Association between low incidence of TP53 mutations and reduced early relapse rates in Uygur DLBCL

Mutibaier Mijiti, Chun Wang, Wenxin Tian, Qiping Shi, Fang Zhang, Renaguli Abulaiti, Xiaolong Qi, Zhen Kou, Cuicui Liu, Zengsheng Wang, Shunsheng Zhai, Li An, Qin Huang, Yang Shao, Guzailinuer Wufuer, Yan Li

The impact of renal function on initial therapy in transplant-ineligible multiple myeloma patients

Yutaka Shimazu, Junya Kanda, Teruhito Takakuwa, Yoshiyuki Onda, Kentaro Fukushima, Masaaki Hotta, Shin-ichi Fuchida, Nobuhiko Uoshima, Yuji Shimura, Hirokazu Tanaka, Kensuke Ohta, Hirohiko Shibayama, Satoru Kosugi, Hideo Yagi, Satoshi Yoshihara, Naoki Hosen, Tomoki Ito, Chihiro Shimazaki, Itaru Matsumura, Junya Kuroda, Akifumi Takaori-Kondo, Masayuki Hino

Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease

Sunil Lakhwani, María Victoria Mateos, Joaquín Martínez-López, Bruno Paiva, Laura Rosiñol Dachs, Rafael Martínez, Albert Oriol, Joan Bargay, Yolanda González-Montes, Mercedes Gironella, Cristina Encinas, Jesús Martín, Isidro Jarque, Miquel Granell, Eugenia Abella, Aránzazu García-Mateo, José Ángel Hernández-Rivas, Elena Ramila, Isabel Krsnik, Luis Felipe Casado Montero, Felipe De Arriba, Luis Palomera, Antonia Sampol, José María Moraleda, María Casanova, Pilar Delgado, Ana Lafuente, Elena Amutio, Aurelio López-Martínez, Albert Altés, M. Ángeles Ruíz, Adrián Alegre, Lucia Lopez-Anglada, Javier De La Cruz, Rafael Alonso Fernández, Joan Bladé Creixenti, Juan-José Lahuerta, Jesús San-Miguel, Miguel-Teodoro Hernández

A simplified geriatric prognostic index to survival in older Asian patients with diffuse large B-Cell lymphoma treated with standard chemo-immunotherapy

Nicole-Ann Lim, Ryan Mao Heng Lim, Zane En Qi Heng, Jing Yuan Tan, Li Mei Michelle Poon, Soon Thye Lim, Jason Yongsheng Chan

Prognosis of patients with Hodgkin lymphoma and indeterminate response to PD-1 inhibitor therapy: considerations for application of LYRIC criteria in real clinical practice

Liudmila Fedorova, Kirill Lepik, Artem Gusak, Polina Kotselyabina, Ivan Moiseev, Vadim Baykov, Natalia Mikhailova, Alexander Kulagin

Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study

Naokazu Nakamura, Nobuyoshi Arima, Teruhito Takakuwa, Satoshi Yoshioka, Kazunori Imada, Kentaro Fukushima, Masaaki Hotta, Shin-ichi Fuchida, Junya Kanda, Nobuhiko Uoshima, Yuji Shimura, Hirokazu Tanaka, Kensuke Ohta, Satoru Kosugi, Hideo Yagi, Satoshi Yoshihara, Ryosuke Yamamura, Yoko Adachi, Hitoshi Hanamoto, Hirohiko Shibayama, Naoki Hosen, Tomoki Ito, Chihiro Shimazaki, Akifumi Takaori-Kondo, Junya Kuroda, Itaru Matsumura, Masayuki Hino

Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experience

Giuseppe Mele, Daniele Derudas, Concetta Conticello, Gregorio Barilà, Massimo Gentile, Stefano Rocco, Salvatore Palmieri, Giulia Palazzo, Candida Germano, Giovanni Reddiconto, Nicola Sgherza, Danilo De Novellis, Carlotta Galeone, Sara Agavni’ Castiglioni, Luca Deiana, Anna Pascarella, Enrica Antonia Martino, Ilaria Foggetti, Ilenia Blasi, Alessandro Spina, Nicola Di Renzo, Alessandro Maggi, Giuseppe Tarantini, Francesco Di Raimondo, Giorgina Specchia, Pellegrino Musto, Domenico Pastore

Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants

María Belén Fontecha, María Del Rosario Anadón, Verónica Mercado Guzmán, Carmen Stanganelli, Camila Galvano, Fernanda Tosin, Javier Bordone, Raimundo Bezares, Cecilia Rodríguez, Viviana Heller, Irma Slavutsky, Ariela Freya Fundia

Multi-center study of COVID-19 infection in elderly patients with lymphoma: on behalf of Jiangsu Cooperative Lymphoma Group (JCLG)

Huayuan Zhu, Xiao Lu, Xiaoping Zhang, Haiying Hua, Jie Zhang, Yuqing Miao, Weiying Gu, Min Xu, Xuzhang Lu, Bingzong Li, Chunling Wang, Haiwen Ni, Jun Qian, Jinning Shi, Maozhong Xu, Guangqi Wu, Yunping Zhang, Qiudan Shen, Zhi Wang, Jianfeng Zhu, Zhen Cheng, Wanchuan Zhuang, Guoqiang Lin, Yongjun Hu, Qiurong Shan, Yifei Chen, Hongchun Qiu, Jianyong Li, Wenyu Shi

Analysis of CCND3 mutations in diffuse large B-cell lymphoma

Wei Hua, Yue Li, Hua Yin, Kai-Xin Du, Xin-Yu Zhang, Jia-Zhu Wu, Jun-Heng Liang, Hao-Rui Shen, Rui Gao, Jian-Yong Li, Li Wang, Jin-Hua Liang, Wei Xu

Treatment outcomes between cyclosporin and chemotherapy in adult subcutaneous panniculitis-like T-cell lymphoma: a report from nation-wide Thai lymphoma study group registry

Thitirat Tirachotikul, Thanawat Rattanathammethee, Nisa Makruasi, Anothai Chintabanyat, Jakrawadee Julamanee, Archrob Khuhapinant, Suporn Chuncharunee, Nonglak Kanitsap, Somchai Wongkhantee, Peerapon Wong, Juthatip Chaloemwong, Pannee Praditsuktavorn, Kannadit Prayongratana, Kanchana Chansung, Pisa Phiphitaporn, Lalita Norasetthada, Tanin Intragumtornchai, Chantana Polprasert, Udomsak Bunworasate

Clonal evolution defines risk stratification for central nervous system leukemia in adult acute lymphoblastic leukemia

Jia Li, Junjie Chen, Qiang Wang, Jiawang Ou, Zicong Huang, Shiyu Deng, Jieping Lin, Zihong Cai, Qifa Liu, HongSheng Zhou

Plerixafor in association with R-DHAP and G-CSF to mobilize a large number of CD34 + cells in patients with relapsed-refractory diffuse large B-cell lymphomas

Francesco Gaudio, Anna Mele, Eleonora Prete, Filomena Emanuela Laddaga, Alessandro Maggi, Nicola Di Renzo, Giuseppe Milone, Angelo Ostuni, Vincenzo Pavone

Effects of different doses of rituximab on immunoglobulin levels in high-risk pediatrics with Burkitt’s lymphoma

Shuang Huang, Ying Li, Yixin Sun, Yaguang Peng, Ling Jin, Jing Yang, Yonghong Zhang, Xiaoling Wang, Yanlong Duan

Mutational heterogeneity in large B-cell lymphoma: insights from paired biopsies

Ditte Stampe Hersby, Lone Schejbel, Marie Fredslund Breinholt, Estrid Høgdall, Peter Nørgaard, Torsten Holm Nielsen, Lars Møller Pedersen, Anne Ortved Gang

Patient-reported outcome domains in multiple myeloma randomized controlled trials and association with survival outcomes

Darshi Shah, Francesco Sparano, Catherine Luo, Daniela Krepper, Johannes M. Giesinger, Thomas Baldi, Eilidh Duncan, Madeline Pe, Rajshekhar Chakraborty, Fabio Efficace

In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzumab

Nashwa Fadaos, Yossi Ben Dor, Tehila Azoulay, Ronit Leiba, Nurit Sharon-Horesh, Tsofia Levi, Netanel A. Horowitz, Inna Tzoran, Noa Lavi, Ofrat Beyar-Katz, Eldad J. Dann, Tsila Zuckerman, Shimrit Ringelstein-Harlev

Primary head and neck lymphoid neoplasms in adolescents and young adults: demographics, distribution and survival outcomes

Ming-Guang Wei, Biao Tian, Jing-Kang Xiong, Juan Feng, Zhen-Tian Wu, Xi Zhang, Yan-Hua Zheng

Incidence and reasons for discontinuation of first-line therapy in patients with multiple myeloma: results from a historical cohort, Brazil 2009–2020

Marina Xavier Teixeira, Adriano Max Moreira Reis, Paula Lana de Miranda Drummond, Jéssica Soares Malta, Lívia Pena Silveira, Cristiane Aparecida Menezes de Pádua

Reappraising the prognostic relevance of cytogenetic risk in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation

Shohei Mizuno, Hiroki Hosoi, Akiyoshi Takami, Takahito Kawata, Noriko Doki, Wataru Takeda, Masatsugu Tanaka, Tetsuya Nishida, Naoyuki Uchida, Yuta Hasegawa, Masashi Sawa, Shuichi Ota, Makoto Onizuka, Hirohisa Nakamae, Noboru Asada, Takahiro Fukuda, Makoto Yoshimitsu, Yoshinobu Kanda, Marie Ohbiki, Yoshiko Atsuta, Takaaki Konuma, Masamitsu Yanada

Clinical data and MRI features-based nomogram for differentiation of central nervous system infection and central nervous system involvement in hematological malignancy

Huiming Yi, Yansong Ren, Shuping Zhang, Chunhui Xu, Wenyu Yang, Xin Chen, Xiaoxue Wang, Ying Zhong, Yingchang Mi, Sizhou Feng

Peculiar hyper vascular manifestations in idiopathic multicentric castleman disease without tafro syndrome: a case report

Rahmeen Khisal Jilani, Muhammad Rizwan Saleem, Shumaila Akhtar, Wajeha Jawad

Case report: VEXAS syndrome with excellent response to treatment with azacitidine

Tzvika Porges, Elli Rosenberg, Ofir Wolach, Iftach Sagy, Yehonatan Sherf, Itai Levi

Novel biallelic GNE variants identified in a patient with chronic thrombocytopenia without any symptoms of myopathy

Shota Tsuda, Atsushi Sakamoto, Hiroyuki Kawaguchi, Toru Uchiyama, Tadashi Kaname, Kumiko Yanagi, Shinji Kunishima, Akira Ishiguro

Identification of a novel cryptic variant chromosomal rearrangement involving 9q34, 22q11.2, and 5q22 resulting in ins(9;22) and t(5;22) in chronic myeloid leukemia: a case report

Firoz Ahmad, Amisha Shah, Meenu Angi, Qurratulain Narmawala, Isha Gupta, Pooja Chaudhary, Ekta Jajodia, Toral Vaishnani, Naman Manguika, Moquitul Haque, Jigar Suthar, Lokesh Patel, Dhanlaxmi Shetty, Spandan Chaudhary, Neeraj Arora

A case of visual impairment due to HHV-6 encephalitis after allogeneic hematopoietic stem cell transplantation in childhood acute myeloid leukemia-M2 subtype

Yan-sha Pan, Hao Li, Min Yang, Chang-ling Zhang, Lan Xiao, Chun-yan Liu, Xue-yan Deng, Xiu-mei Xu, You Yang, Wen-jun Liu

Pyoderma gangrenosum-like neutrophilic dermatosis as an adverse effect of menin-KMT2A inhibitor therapy for acute myeloid leukaemia

Urbain Tauveron-Jalenques, Khadim Sarr, Romain Guièze, Chloé Giordano, Jacques Rouanet, Sandrine Hayette, Carole Chevenet, Maël Heiblig, Aurélie Ravinet

Post-transplant transient abnormal myelopoiesis evolving from a GATA1 mutant clone in umbilical cord blood

Yusuke Kubota, Masatoshi Sakurai, Yasuhito Nannya, Yasunori Kogure, Kohei Shiroshita, Shinya Fujita, Kentaro Yamaguchi, Kota Mizuno, Jun Kato, Takehiko Mori, Seishi Ogawa, Keisuke Kataoka

Donor selection for allogeneic hematopoietic cell transplant in a patient with JAK2 V617F primary myelofibrosis and SH2B3/LNK germline variant

Giorgia Ranucci, Camilla Page, Enrica Marchionni, Chiara Minotti, Giorgia Silvestrini, Susanna Gastaldi, Giada Pacitto, Laura Cicconi, Annalisa Biagi, Valentina Ferradini, Enrico Attardi, Giuseppe Novelli, Federica Sangiuolo, Maria Teresa Voso, Carmelo Gurnari

Chidamide combined with azacitidine as a novel double epigenetic preemptive treatment for a myelodysplastic syndrome patient showing molecular relapse after allogeneic hematopoietic stem cell transplantation

Fang-Tong Liu, Chao-Ling Wan, Yuan-Hong Huang, Han-Yu Cao, Xiao-Yu Lyu, Zi-Hao Wang, Si-Man Huang, Kai-Wen Tan, Shuai-Shuai Ge, Yang Zhang, Sheng-Li Xue

Ischemic stroke as a presenting feature of promyelocytic blast phase in chronic myeloid leukemia – an uncommon presentation: a case report and literature review in the post imatinib era

Swapnil Tripathi, Vinu Balraam K. V., Amiya Ranjan Nayak, Richa Chauhan, Pradeep Kumar, Jasmita Dass, Priyanka Naranje, Mukul Aggarwal

Adipopenia is associated with poor outcomes in elderly patients with B-cell lymphoma

Saori Kadota, Moe Masuda, So Okubo, Kohei Shinmura, Hitomi Nakayama, Shuhei Kurosawa, Chisako Ito, Aki Sakurai, Yoshinobu Aisa, Tomonori Nakazato

Broadening perspectives: redefining the role of obesity in ITP

Chenglong Liang, Chen Zhou, Jingye Pan

Analysis of a plerixafor sparing mobilization regimen for autologous hematopoietic cell transplant in multiple myeloma

Daniel Cancilla, Daniel Paul Nurse, Wei Wei, Danielle Cenin, Christina Ferraro, Christopher D’Andrea, Brian Matia, Julie Coffman, Betty K. Hamilton, Swati Srivastava, Craig Sauter, Louis Williams, Jack Khouri

CD19 CAR T-cell therapy in relapsed TCF3-HLF-positive B-cell acute lymphoblastic leukemia

Yao Yao, Jin Zhou, Yanting Li, Sensen Shi, Lei Yu, Depei Wu, Ying Wang

The second adult case of NUTM1 fusion-positive B-cell lymphoblastic leukemia: A recurring pattern of poor prognosis

Xue Chen, Xiaoli Ma, Lili Yuan, Fang Wang, Yang Zhang, Panxiang Cao, Yue Lu, Jiaqi Chen, Xiaosu Zhou, Hongxing Liu

Management of latent tuberculosis infection (LTBI) in adult patients with newly diagnosed acute leukemia: results of a survey among Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group

Fabio Forghieri, Francesca Bettelli, Simona Sgromo, Gianpaolo Nadali, Maria Ilaria Del Principe, Elisa Buzzatti, Francesca Farina, Laura Cesini, Antonio Giordano, Marianna Criscuolo, Davide Facchinelli, Monica Piedimonte, Chiara Sartor, Roberta De Marchi, Mario Delia, Federico Mosna, Laura Cudillo, Giulia Tolomelli, Claudia Maria Basilico, Chiara Cattaneo, Nicola Stefano Fracchiolla, Federica Lessi, Olimpia Finizio, Beatrice Anna Zannetti, Adele Santoni, Paola Fazi, Francesco Marchesi, Adriano Venditti, Anna Candoni, Mario Luppi, Alessandro Busca, Livio Pagano

Therapy-related myeloid neoplasms: a real-world pharmacovigilance analysis (1970–2023)

Shiva Jashwanth Gaddam, Udhayvir Singh Grewal, Sindhu Thevuthasan, Poornima Ramadas

Hepatosplenic αβ T-cell lymphoma with peripheral blood involvement as initial presentation

Ting Li, Ping Wu, Aixian Wang, Man Chen, Minjing Fu, Hui Wang

Correction to: Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia

Maximilian Fleischmann, Madlen Jentzsch, Annamaria Brioli, Florian Eisele, Jochen J Frietsch, Farina Eigendorff, Romy Tober, Karin G Schrenk, Jakob Friedrich Hammersen, Olaposi Yomade, Inken Hilgendorf, Andreas Hochhaus, Sebastian Scholl, Ulf Schnetzke

Keynote webinar | Spotlight on progress in colorectal cancer

On-demand video coming soon

CRC remains a major global health burden, but advances in screening, treatment, and lifestyle-based prevention continue to reshape clinical practice. Gain insights into how the latest research can be leveraged to optimize patient care across the CRC continuum.

Prof. Antoni Castells
Prof. Harpreet Wasan
Prof. Edward Giovannucci
Notify me

Keynote webinar | Spotlight on functional neurological disorder

FND perplexes and frustrates patients and physicians alike. Limited knowledge and insufficient awareness delays diagnosis and treatment, and many patients feel misunderstood and stigmatized. How can you recognize FND and what are the treatment options?

Prof. Mark Edwards
Watch now
Video
Image Credits
Colon cancer illustration/© (M) KATERYNA KON / SCIENCE PHOTO LIBRARY / Getty Images, Human brain illustration/© (M) CHRISTOPH BURGSTEDT / SCIENCE PHOTO LIBRARY / Getty Images